Detalhe da pesquisa
1.
Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
Ann Oncol
; 28(7): 1554-1559, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379307
2.
A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome.
Eur J Cancer Care (Engl)
; 22(5): 605-11, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23701251
3.
Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
J Exp Med
; 177(3): 763-74, 1993 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8382256
4.
LIF: not just a leukemia inhibitory factor.
Endocr Rev
; 12(3): 208-17, 1991 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-1935819
5.
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway.
Leukemia
; 32(4): 960-970, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972595
6.
Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.
J Clin Invest
; 94(4): 1383-9, 1994 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-7929813
7.
1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.
J Clin Invest
; 100(7): 1716-24, 1997 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9312169
8.
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.
J Clin Invest
; 108(6): 851-9, 2001 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-11560954
9.
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.
Leukemia
; 31(2): 318-324, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795561
10.
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.
Leukemia
; 31(7): 1659, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28338082
11.
Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
Cancer Res
; 48(20): 5901-7, 1988 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-3048651
12.
Heterogeneity in lineage derivation of Philadelphia-positive acute lymphoblastic leukemia expressing p190BCR-ABL or p210BCR-ABL: determination by analysis of individual colonies with the polymerase chain reaction.
Cancer Res
; 53(14): 3289-93, 1993 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-8324740
13.
Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
Cancer Res
; 54(7): 1837-42, 1994 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8137298
14.
Characterization of malignant peripheral blood cells of juvenile chronic myelogenous leukemia.
Cancer Res
; 46(12 Pt 1): 6456-61, 1986 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-3465439
15.
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS.
Cancer Res
; 59(12): 2971-80, 1999 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-10383163
16.
Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death.
Cancer Res
; 61(1): 138-44, 2001 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11196151
17.
Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
Oncogene
; 35(43): 5663-5673, 2016 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27065330
18.
Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity.
J Clin Oncol
; 16(4): 1526-31, 1998 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9552062
19.
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure.
J Clin Oncol
; 9(7): 1241-50, 1991 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-2045865
20.
Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts.
J Clin Oncol
; 9(3): 394-9, 1991 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-1999709